HER2, also known as ERBB2, NEU, and CD34, is a human epidermal growth factor receptor 2 and a component of transmembrane glycoprotein that is overexpressed in approximately 20–30% of primary breast carcinomas [47,57] for tyrosine kinase activity. This evidence concerns the gene ERBB2 and breast carcinoma.